Xinhua Lande Scitech Co., Limited (HKG:8106)
Hong Kong · Delayed Price · Currency is HKD 0.2650
+0.0100 (3.92%)
Jun 11, 2026, 10:18 AM HKT
Xinhua Lande Scitech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 230.25 | 185.04 | 98.09 | 135.02 | 206.05 | |
Revenue Growth (YoY) | 24.43% | 88.65% | -27.35% | -34.47% | -13.29% |
Cost of Revenue | 203.09 | 164.15 | 86.55 | 119.24 | 165.44 |
Gross Profit | 27.16 | 20.9 | 11.54 | 15.79 | 40.61 |
Selling, General & Admin | 18.1 | 17.32 | 21.79 | 23.35 | 25.27 |
Research & Development | 2.49 | 4.45 | 13.19 | 9.83 | 8.65 |
Other Operating Expenses | 2.27 | 4.71 | 17.16 | 2.83 | -1.03 |
Operating Expenses | 22.86 | 26.47 | 52.14 | 36.01 | 32.89 |
Operating Income | 4.3 | -5.57 | -40.6 | -20.23 | 7.72 |
Interest Expense | -0.92 | -0.68 | -0.35 | -0.3 | -0.07 |
Interest & Investment Income | 0.09 | 0.11 | 0.95 | 0.59 | 0.6 |
Earnings From Equity Investments | - | - | - | - | 0.09 |
Currency Exchange Gain (Loss) | -0.06 | -0.01 | -0.02 | 0.76 | -0.7 |
EBT Excluding Unusual Items | 3.42 | -6.15 | -40.03 | -19.18 | 7.64 |
Impairment of Goodwill | - | - | -1.86 | - | - |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.37 |
Gain (Loss) on Sale of Assets | 0.03 | -0.01 | -0.21 | - | - |
Other Unusual Items | - | - | - | - | 0.47 |
Pretax Income | 3.44 | -6.16 | -42.09 | -19.18 | 8.47 |
Income Tax Expense | 2.36 | 0.34 | 0.68 | -0.17 | 0.93 |
Earnings From Continuing Operations | 1.09 | -6.51 | -42.77 | -19.01 | 7.55 |
Earnings From Discontinued Operations | - | - | - | 2.84 | -6.88 |
Net Income to Company | 1.09 | -6.51 | -42.77 | -16.17 | 0.67 |
Net Income | 1.09 | -6.51 | -42.77 | -16.17 | 0.67 |
Net Income to Common | 1.09 | -6.51 | -42.77 | -16.17 | 0.67 |
Net Income Growth | - | - | - | - | -86.77% |
Shares Outstanding (Basic) | 507 | 507 | 507 | 507 | 507 |
Shares Outstanding (Diluted) | 507 | 507 | 507 | 507 | 507 |
EPS (Basic) | 0.00 | -0.01 | -0.08 | -0.03 | 0.00 |
EPS (Diluted) | 0.00 | -0.01 | -0.08 | -0.03 | 0.00 |
EPS Growth | - | - | - | - | -86.77% |
Free Cash Flow | 4.8 | -16.03 | -27.94 | -41.09 | -5.7 |
Free Cash Flow Per Share | 0.01 | -0.03 | -0.06 | -0.08 | -0.01 |
Gross Margin | 11.80% | 11.29% | 11.77% | 11.69% | 19.71% |
Operating Margin | 1.87% | -3.01% | -41.39% | -14.98% | 3.74% |
Profit Margin | 0.47% | -3.52% | -43.61% | -11.97% | 0.32% |
Free Cash Flow Margin | 2.09% | -8.66% | -28.48% | -30.43% | -2.77% |
EBITDA | 4.87 | -4.86 | -39.66 | -18.51 | 8.76 |
EBITDA Margin | 2.11% | -2.63% | -40.43% | -13.71% | 4.25% |
D&A For EBITDA | 0.56 | 0.72 | 0.94 | 1.71 | 1.04 |
EBIT | 4.3 | -5.57 | -40.6 | -20.23 | 7.72 |
EBIT Margin | 1.87% | -3.01% | -41.39% | -14.98% | 3.74% |
Effective Tax Rate | 68.43% | - | - | - | 10.93% |